The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

Empowering the Next Generation of Cancer Research Advocates: Community Engagement Across the Research Continuum Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are ...

In 2018, three back-to-back publications unraveled the role of the gut microbiota—a rich organ within the gastrointestinal tract primarily composed of 10 13 commensal bacteria—in modulating ICI ...

The global discourse surrounding ENDS has generated insightful perspectives, but these may not fully align with the realities of LMICs still battling higher (than global average) tobacco use rates.

Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...

Toward Functional Biomarkers of Response to Neoadjuvant Oncolytic Virus in Stage II Melanoma: Immune-Förster Resonance Energy Transfer and the Dynamic Tumor Immune Microenvironment This ...

Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease This multicenter retrospective study included patients ...

Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials ...

Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not? The following represents disclosure information provided by authors of this manuscript. All relationships are ...